https://www.selleckchem.com/btk.html
Stroke is the second leading cause of death worldwide. If risk of stroke could be evaluated early or even at a preclinical stage, the mortality rate could be reduced dramatically. However, the identified genetic factors only account for 5-10% of the risk of stroke. Studies on the risk factors of stroke are urgently needed. We investigated the correlation between blood-based β-actin ( ) methylation and the risk of stroke in a prospective nested case-control study. The methylation level of was quantitatively determined by mass spectrometry in 139 stro
إعجاب
علق
شارك
